FXEMPIRE
All
Ad
Corona Virus
Stay Safe, FollowGuidance
World
41,043,648Confirmed
1,129,600Deaths
30,629,580Recovered
Fetching Location Data…
Advertisement
Advertisement
Vivek Kumar
cloud minig

Coupa Software Inc’s price target was raised to $330 from $272 with ‘Overweight’ stock rating, according to Morgan Stanley equity analyst Stan Zlotsky, who also said sees a solid execution coupled with improving macro setting up the company well for a potential FY22 growth re-acceleration.

Early this month, the cloud-based expense management platform reported total revenue of $125.9 million, an increase of 32% compared to the same period last year. Subscription revenues were $111.6 million, an increase of 34% compared to the same period last year.

The company forecasts total revenues between $123.0 to $124.0 million for the third quarter and between $496.5 to $498.5 million for the full-year fiscal 2021.

“Most investors clearly see the impact COVID has had on Coupa’s growth in FY21, which we think creates an opportunity to own one of the premier SaaS assets ahead of a potential growth acceleration into FY22,” Morgan Stanley’s Adam Jonas said.

“We see a fairly clear runway for Coupa getting to mid-30% revenue growth in FY22 through: 1) organic growth of 25-30%; 2) Coupa Pay starting to hit revenue more materially – we estimate ~$60M potential; 3) $20-$25 million from Bellin acquisition; 4) $10-$15 million from Yapta acquisition as corporate travel resumes. Compared to current consensus FY22 growth of ~26%, we see the potential for Coupa to deliver the beat/raise cadence moving forward and outperform Street expectations through the year.”

At the time of writing, Coupa stock traded 1.5% higher at $272.15 on Wednesday; however, the stock is up over 80% so far this year.

Several other equity analysts have also updated their stock outlook. KeyCorp increased their price target on Coupa Software to $325 from $320 and gave the stock an “overweight” rating. Raymond James increased their price target to $300 from $235 and gave the stock an “outperform” rating. Truist increased their price target to $300 from $240.

Seventeen analysts forecast the average price in 12 months at $291.53 with a high forecast of $339.00 and a low forecast of $232.00. The average price target represents a 6.52% increase from the last price of $273.68. From those 17 equity analysts, 11 rated ‘Buy’, six rated ‘Hold’ and none rated ‘Sell’, according to Tipranks.

“In an uncertain macro environment, we expect relative outperformance in COUP due to  1) defensive nature of Coupa’s core business spend management (BSM) offering, 2) expanding TAM from entry into B2B payments (Coupa Pay) and 3) rapidly improving profitability – all of which drive durable LT growth, in our view,” Morgan Stanley’s Stan Zlotsky added.

“Our $330 price target is based on combining our $193 base case value for the core BSM business and our conservative Coupa Pay estimates, which imply $137 of incremental value. Our price target implies 33X CY21 EV/Sales and 0.94x growth adjusted vs. SaaS peers at 0.56x, a premium we think is appropriate given model conservatism, higher contribution margins from Coupa Pay and sustainability of long-term growth.”

Upside risk: Coupa Pay gains adoption faster than expected, opening a potentially large incremental TAM opportunity, highlighted by Morgan Stanley.

Downside risks: Increased competition from large, well established ERP vendors like Oracle and SAP Ariba. Prolonged macro slowdown limits new customer growth and share gains.

Advertisement
Don't miss a thing!
Discover what's moving the markets. Sign up for a daily update delivered to your inbox

Trade With A Regulated Broker

  • Your capital is at risk
IMPORTANT DISCLAIMERS
The content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your own due diligence checks, apply your own discretion and consult your competent advisors. The content of the website is not personally directed to you, and we does not take into account your financial situation or needs.The information contained in this website is not necessarily provided in real-time nor is it necessarily accurate. Prices provided herein may be provided by market makers and not by exchanges.Any trading or other financial decision you make shall be at your full responsibility, and you must not rely on any information provided through the website. FX Empire does not provide any warranty regarding any of the information contained in the website, and shall bear no responsibility for any trading losses you might incur as a result of using any information contained in the website.The website may include advertisements and other promotional contents, and FX Empire may receive compensation from third parties in connection with the content. FX Empire does not endorse any third party or recommends using any third party's services, and does not assume responsibility for your use of any such third party's website or services.FX Empire and its employees, officers, subsidiaries and associates, are not liable nor shall they be held liable for any loss or damage resulting from your use of the website or reliance on the information provided on this website.
RISK DISCLAIMER
This website includes information about cryptocurrencies, contracts for difference (CFDs) and other financial instruments, and about brokers, exchanges and other entities trading in such instruments. Both cryptocurrencies and CFDs are complex instruments and come with a high risk of losing money. You should carefully consider whether you understand how these instruments work and whether you can afford to take the high risk of losing your money.FX Empire encourages you to perform your own research before making any investment decision, and to avoid investing in any financial instrument which you do not fully understand how it works and what are the risks involved.
FOLLOW US